Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems

Electronic Journal of Biotechnology

Volumn 5, Issue 3, 2002, Pages 243-250

  Fogolín, Mariela Bollati ^a   Eberhardt, Marcos Oggero ^a   Kratje, Ricardo ^a   Etcheverrigaray, Marina ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Bioassay; ELISA; GM CSF; Monoclonal antibody; Quantification

Indexed keywords

EID: 54049118711     PISSN: 07173458     EISSN: 07173458     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. BAYER, E.A. and WILCHEK, M. The use of avidin-biotin complex as a tool in molecular biology. Methods of Biochemical Analysis, January 1980, vol. 26, p. 1-45.
2. th June, 2000, Santa Fe, Argentina). Abstracts, 2000. p. 65.
3. CEBON, J.; DEMPSEY, P.; FOX, R.; KANNOURAKIS, G.; BONNEM, E.; BURGESS, A.W. and MORSTYN, G. Pharmacokinetics of Human Granulocyte-Macrophage Colony-Stimulating Factor using a sensitive immunoassay. Blood, October 1988, vol. 72, p. 1340-1347.
4. DORR, R.T. Clinical properties of yeast-derived versus Escherichia coli - derived granulocyte macrophage colony-stimulating factor. Clinical Therapeutics, January 1993, vol. 15, no. 1, p. 19-29.
5. th September, 1997, Tours, Val de Loire, France). New Developments and New Applications in Animal Cell Technology, Kluwer Academic Publishers, Dordrecht, The Netherlands. GRIFFITHS, J.B. and MERTEN, O.W. eds., 1998. p. 163-165.
6. GALFRÉ, G. and MILSTEIN, C. Preparation of monoclonal antibodies: Strategies and procedures. Methods in Enzymology, August 1981, vol. 73, p. 3-47.
7. HUSSEIN, A.M.; ROSS, M.; VREDENBURGH, J.; MEISENBERG, B.; HARS, V.; GILBERT, C.; PETROS, W.P.; CONIGLIO, D.; KURTZBERG, J.; RUBIN, P. and PETERS, W.P. Effects of granulocyte-macrophage colony stimulating factor produced in CHO (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. European Journal of Haematology, 1995, vol. 54, p. 281-287.
8. METCALF, D. The granulocyte-macrophage colony stimulating factors. Science, July 1985, vol. 229, p. 16-22.
9. MIRE-SLUIS, A.R. and THORPE, R. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. Journal of Immunological Methods, February 1998, vol. 211, no. 1-2, p. 199-210.
10. MIRE-SLUIS, A.R.; GAINES-DAS, R. and THORPE, R. The International Standard for Granulocyte-Colony Stimulating Factor (G-CSF): Evaluation in an International Collaborative Study. Participants of the Collaborative Study. Journal of Immunological Methods, February 1995a, vol. 179, no. 1, p. 117-126.
11. MIRE-SLUIS, A.R.; GAINES-DAS, R. and THORPE, R. The International Standard for Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF): Evaluation in an International Collaborative Study. Participants of the Collaborative Study. Journal of Immunological Methods, February 1995b, vol. 179, no. 1, p. 127-135.
12. NICOLA N.A. Granulocyte-macrophage colony-stimulating factor (GM-CSF). In: Guidebook to Cytokines and their Receptors. Oxford University Press, Oxford, UK, 1994, p. 171-173.
13. th June, 2001, Tylösand, Sweden). Animal Cell Technology: From Targent to Market, Kluwer Academic Publishers, Dordrecht, The Netherlands. LINDNER OLSSON, E.; CHATZISSAVIDOU, N. and LÜLLAU, E. eds., 2001. p. 23-25.
14. THING MORTENSEN, B.; SCHIFTER, S.; BREDO PEDERSEN, L.; NYMARK JENSEN, A.; HOVGAARD, D. and NISSEN, N.I. Development and application of a sensitive radioimmunoassay for human granulocyte-macrophage colony stimulating factor able to measure normal concentrations in blood. Experimental Hematology, September 1993, vol. 21, no. 10, p. 1366 -1370.